https://www.selleckchem.com/pr....oducts/cabotegravir-
Moreover, GSEA revealed that various immune-related pathways might be regulated by SUCNR1. In addition, we found that SUCNR1 was amplified in ovarian cancer, and the high expression of SUCNR1 predicted worse progression-free survival ( = 0.0073, HR = 1.49, 95% CI = 1.11-2). These results highlight the role of SUCNR1 in regulating tumor immunity in ovarian cancer. These results highlight the role of SUCNR1 in regulating tumor immunity in ovarian cancer.Background Deep brain stimulation (DBS) is a therapy for moveme
Like
Comment
Share
